Phathom Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases in the United States. It develops VOQUEZNA, which has completed Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease...
29 insider purchases on record · latest filing 2025-05-23.
Insiders have also filed 166 sale transactions at PHAT.